202 related articles for article (PubMed ID: 24495669)
21. Animal models for anti-angiogenic therapy in endometriosis.
Edwards AK; Nakamura DS; Virani S; Wessels JM; Tayade C
J Reprod Immunol; 2013 Mar; 97(1):85-94. PubMed ID: 23432875
[TBL] [Abstract][Full Text] [Related]
22. Protein kinase inhibitors can control the progression of endometriosis in vitro and in vivo.
Ngô C; Nicco C; Leconte M; Chéreau C; Arkwright S; Vacher-Lavenu MC; Weill B; Chapron C; Batteux F
J Pathol; 2010 Oct; 222(2):148-57. PubMed ID: 20821752
[TBL] [Abstract][Full Text] [Related]
23. Effect of antiangiogenic treatment on peritoneal endometriosis-associated nerve fibers.
Novella-Maestre E; Herraiz S; Vila-Vives JM; Carda C; Ruiz-Sauri A; Pellicer A
Fertil Steril; 2012 Nov; 98(5):1209-17. PubMed ID: 22921078
[TBL] [Abstract][Full Text] [Related]
24. Blocking of stromal cell-derived factor-1 reduces neoangiogenesis in human endometriosis lesions in a mouse model.
Virani S; Edwards AK; Thomas R; Childs T; Tayade C
Am J Reprod Immunol; 2013 Nov; 70(5):386-97. PubMed ID: 23650939
[TBL] [Abstract][Full Text] [Related]
25. [Study of tissue morphology and vascular endothelial growth factor and matrix metalloproteinase-9 gene expressions in nude mouse endometriosis model].
Wang DB; Zhang SL; Niu HY; Lu JM
Zhonghua Fu Chan Ke Za Zhi; 2004 Nov; 39(11):759-62. PubMed ID: 15634503
[TBL] [Abstract][Full Text] [Related]
26. Prodrug of green tea epigallocatechin-3-gallate (Pro-EGCG) as a potent anti-angiogenesis agent for endometriosis in mice.
Wang CC; Xu H; Man GC; Zhang T; Chu KO; Chu CY; Cheng JT; Li G; He YX; Qin L; Lau TS; Kwong J; Chan TH
Angiogenesis; 2013 Jan; 16(1):59-69. PubMed ID: 22948799
[TBL] [Abstract][Full Text] [Related]
27. Epigallocatechin-3-gallate inhibits estrogen-induced activation of endometrial cells in vitro and causes regression of endometriotic lesions in vivo.
Laschke MW; Schwender C; Scheuer C; Vollmar B; Menger MD
Hum Reprod; 2008 Oct; 23(10):2308-18. PubMed ID: 18603648
[TBL] [Abstract][Full Text] [Related]
28. Vascular disrupting effects of combretastatin A4 phosphate on murine endometriotic lesions.
Feng D; Menger MD; Laschke MW
Fertil Steril; 2013 Nov; 100(5):1459-67. PubMed ID: 23993929
[TBL] [Abstract][Full Text] [Related]
29. The relationship between microvessel density, proliferative activity and expression of vascular endothelial growth factor-A and its receptors in eutopic endometrium and endometriotic lesions.
Bourlev V; Volkov N; Pavlovitch S; Lets N; Larsson A; Olovsson M
Reproduction; 2006 Sep; 132(3):501-9. PubMed ID: 16940291
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and antivascular effects of EphA2 reduction with an agonistic antibody in ovarian cancer.
Landen CN; Lu C; Han LY; Coffman KT; Bruckheimer E; Halder J; Mangala LS; Merritt WM; Lin YG; Gao C; Schmandt R; Kamat AA; Li Y; Thaker P; Gershenson DM; Parikh NU; Gallick GE; Kinch MS; Sood AK
J Natl Cancer Inst; 2006 Nov; 98(21):1558-70. PubMed ID: 17077358
[TBL] [Abstract][Full Text] [Related]
31. Vascular endothelial growth factor C is increased in endometrium and promotes endothelial functions, vascular permeability and angiogenesis and growth of endometriosis.
Xu H; Zhang T; Man GC; May KE; Becker CM; Davis TN; Kung AL; Birsner AE; D'Amato RJ; Wong AW; Wang CC
Angiogenesis; 2013 Jul; 16(3):541-51. PubMed ID: 23334337
[TBL] [Abstract][Full Text] [Related]
32. Identification and quantification of dopamine receptor 2 in human eutopic and ectopic endometrium: a novel molecular target for endometriosis therapy.
Novella-Maestre E; Carda C; Ruiz-Sauri A; Garcia-Velasco JA; Simon C; Pellicer A
Biol Reprod; 2010 Nov; 83(5):866-73. PubMed ID: 20574053
[TBL] [Abstract][Full Text] [Related]
33. Activation of protease-activated receptor 2 stimulates proliferation and interleukin (IL)-6 and IL-8 secretion of endometriotic stromal cells.
Hirota Y; Osuga Y; Hirata T; Harada M; Morimoto C; Yoshino O; Koga K; Yano T; Tsutsumi O; Taketani Y
Hum Reprod; 2005 Dec; 20(12):3547-53. PubMed ID: 16096323
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of MAPK and VEGFR by Sorafenib Controls the Progression of Endometriosis.
Leconte M; Santulli P; Chouzenoux S; Marcellin L; Cerles O; Chapron C; Dousset B; Batteux F
Reprod Sci; 2015 Sep; 22(9):1171-80. PubMed ID: 26169036
[TBL] [Abstract][Full Text] [Related]
35. Nobiletin alleviates endometriosis via down-regulating NF-κB activity in endometriosis mouse model.
Wei X; Shao X
Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29871974
[TBL] [Abstract][Full Text] [Related]
36. Vascular endothelial growth factor tyrosine kinase inhibitor AZD2171 and fractionated radiotherapy in mouse models of lung cancer.
Cao C; Albert JM; Geng L; Ivy PS; Sandler A; Johnson DH; Lu B
Cancer Res; 2006 Dec; 66(23):11409-15. PubMed ID: 17145887
[TBL] [Abstract][Full Text] [Related]
37. A selective cyclooxygenase-2 inhibitor suppresses the growth of endometriosis xenografts via antiangiogenic activity in severe combined immunodeficiency mice.
Ozawa Y; Murakami T; Tamura M; Terada Y; Yaegashi N; Okamura K
Fertil Steril; 2006 Oct; 86(4 Suppl):1146-51. PubMed ID: 16962108
[TBL] [Abstract][Full Text] [Related]
38. Effect of rapamycin alone and in combination with sorafenib in an orthotopic model of human hepatocellular carcinoma.
Wang Z; Zhou J; Fan J; Qiu SJ; Yu Y; Huang XW; Tang ZY
Clin Cancer Res; 2008 Aug; 14(16):5124-30. PubMed ID: 18698030
[TBL] [Abstract][Full Text] [Related]
39. The indazole derivative YD-3 specifically inhibits thrombin-induced angiogenesis in vitro and in vivo.
Peng CY; Pan SL; Pai HC; Tsai AC; Guh JH; Chang YL; Kuo SC; Lee FY; Teng CM
Shock; 2010 Dec; 34(6):580-5. PubMed ID: 20351626
[TBL] [Abstract][Full Text] [Related]
40. Effect of aromatase inhibitors on ectopic endometrial growth and peritoneal environment in a mouse model of endometriosis.
Bilotas M; Meresman G; Stella I; Sueldo C; Barañao RI
Fertil Steril; 2010 May; 93(8):2513-8. PubMed ID: 19819437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]